Hepatic dysfunction and jaundice following high-dose cytosine arabinoside.

George, C B; Mansour, R P; Redmond, J; Gandara, D R

George, C B; Mansour, R P; Redmond, J; Gandara, D R.

Cancer ; 54(11): 2360-2, 1984 Dec 01.

Article in En | MEDLINE | ID: mdl-6594185

Subject(s)

Cholestasis/chemically induced; Cytarabine/adverse effects; Leukemia, Lymphoid/drug therapy; Leukemia, Myeloid/drug therapy; Liver/pathology; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Cholestasis/pathology; Cyclophosphamide/administration & dosage; Cytarabine/therapeutic use; Doxorubicin/administration & dosage; Humans; Liver/drug effects; Male; Middle Aged; Prednisone/administration & dosage; Vincristine/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphoid / Leukemia, Myeloid / Cholestasis / Cytarabine / Liver Type of study: Prognostic_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: Cancer Year: 1984 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links